APA

Brennan A. T., Davies M., Bor J., Wandeler G., Stinson K., Wood R., Prozesky H., Tanser F., Fatti G., Boulle A., Sikazwe I., Wool-Kaloustian K., Yuannoutsos C., Leroy V., de Rekeneire N. & Fox M. P. (20171220). Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?. : AIDS (London, England).

Chicago

Brennan Alana T, Davies Mary-Ann, Bor Jacob, Wandeler Gilles, Stinson Kathryn, Wood Robin, Prozesky Hans, Tanser Frank, Fatti Geoffrey, Boulle Andrew, Sikazwe Izukanji, Wool-Kaloustian Kara, Yuannoutsos Constantin, Leroy Valériane, de Rekeneire Nathalie and Fox Matthew P. 20171220. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?. : AIDS (London, England).

Harvard

Brennan A. T., Davies M., Bor J., Wandeler G., Stinson K., Wood R., Prozesky H., Tanser F., Fatti G., Boulle A., Sikazwe I., Wool-Kaloustian K., Yuannoutsos C., Leroy V., de Rekeneire N. and Fox M. P. (20171220). Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?. : AIDS (London, England).

MLA

Brennan Alana T, Davies Mary-Ann, Bor Jacob, Wandeler Gilles, Stinson Kathryn, Wood Robin, Prozesky Hans, Tanser Frank, Fatti Geoffrey, Boulle Andrew, Sikazwe Izukanji, Wool-Kaloustian Kara, Yuannoutsos Constantin, Leroy Valériane, de Rekeneire Nathalie and Fox Matthew P. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?. : AIDS (London, England). 20171220.